Cargando…

YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达

OBJECTIVE: YKL-40, also known as chitinase-3-like-1 (CHI3L1), is a human cartilage glycoprotein-39, with its N-terminus consisting of tyrosine (Y), lysine (K), and leucine (L), hence the name YKL-40. In this study, we explored whether YKL-40 could promote the expression of inflammatory factors in ty...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 四川大学学报(医学版)编辑部 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579078/
https://www.ncbi.nlm.nih.gov/pubmed/37866952
http://dx.doi.org/10.12182/20230960201
_version_ 1785121644925157376
collection PubMed
description OBJECTIVE: YKL-40, also known as chitinase-3-like-1 (CHI3L1), is a human cartilage glycoprotein-39, with its N-terminus consisting of tyrosine (Y), lysine (K), and leucine (L), hence the name YKL-40. In this study, we explored whether YKL-40 could promote the expression of inflammatory factors in type Ⅱ alveolar epithelial cells. METHODS: A549 cells were cultured in vitro with interleukin (IL)-1β (20 ng/mL), IL-6 (20 ng/mL), tumor necrosis factor-alpha (TNF-α) (20 ng/mL), and interferon-gamma (IFN-γ) (20 ng/mL). The expression of YKL-40 transcription was determined by RT-qPCR. A549 cells were cultured with IL-1β at 5, 10, and 20 ng/mL and the expression of YKL-40 protein was determined by Western blot. A549 cells were cultured with recombinant YKL-40 protein at 0, 100, 500, and 1000 ng/mL and the expression levels of IL-6 and IL-8 were measured by RT-qPCR. Three pairs of small interfering RNAs targeting YKL-40 (si-YKL-40-1/2/3) and the negative control (NC) were designed and used to transfect A549 cells, respectively, and the expression of YKL-40 was determined by RT-qPCR and Western blot. si-YKL-40-3 was screened out for subsequent experiments. In A549 cells, si-YKL-40-3 and si-NC were transfected and, then, IL-1β (20 ng/mL) was added in for culturing. The expression of YKL-40, IL-6, and IL-8 was determined by RT-qPCR and the expression of multiple factors in the supernatant was measured with the QAH-INF-1 kit. RESULTS: RT-qPCR results showed that IL-1β could up-regulate YKL-40 protein transcription level compared with that of the control group and the difference was statistically significant (P<0.01), but IL-6, TNF-α, and IFN-γ could not up-regulate YKL-40 protein transcription level. Western blot results showed that IL-1β (20 ng/mL) could significantly promote the expression of YKL-40 and, compared with that of the control group, the differences showed by groups treated with different concentrations of IL-1β were all statistical significant (P<0.01). After adding human recombinant YKL-40 protein to A549 cells, the results showed that the expression of inflammatory factors IL-6 and IL-8 was significantly increased and the difference was statistically significant compared with that of the control group (P<0.05). After the expression of YKL-40 was decreased by si-YKL-40-3 transfection, the expression of IL-6 (P<0.05), IL-8 (P<0.05), and other inflammatory factors was inhibited compared with that of the control group. CONCLUSION: YKL-40 can promote the expression and secretion of IL-6, IL-8, and other acute inflammatory factors in A549 cell line, a type Ⅱ alveolar epithelial cell model, thus aggravating the inflammatory response. Targeted inhibition of YKL-40 expression may effectively inhibit inflammatory response.
format Online
Article
Text
id pubmed-10579078
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher 四川大学学报(医学版)编辑部
record_format MEDLINE/PubMed
spelling pubmed-105790782023-10-18 YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达 Sichuan Da Xue Xue Bao Yi Xue Ban 论 著 OBJECTIVE: YKL-40, also known as chitinase-3-like-1 (CHI3L1), is a human cartilage glycoprotein-39, with its N-terminus consisting of tyrosine (Y), lysine (K), and leucine (L), hence the name YKL-40. In this study, we explored whether YKL-40 could promote the expression of inflammatory factors in type Ⅱ alveolar epithelial cells. METHODS: A549 cells were cultured in vitro with interleukin (IL)-1β (20 ng/mL), IL-6 (20 ng/mL), tumor necrosis factor-alpha (TNF-α) (20 ng/mL), and interferon-gamma (IFN-γ) (20 ng/mL). The expression of YKL-40 transcription was determined by RT-qPCR. A549 cells were cultured with IL-1β at 5, 10, and 20 ng/mL and the expression of YKL-40 protein was determined by Western blot. A549 cells were cultured with recombinant YKL-40 protein at 0, 100, 500, and 1000 ng/mL and the expression levels of IL-6 and IL-8 were measured by RT-qPCR. Three pairs of small interfering RNAs targeting YKL-40 (si-YKL-40-1/2/3) and the negative control (NC) were designed and used to transfect A549 cells, respectively, and the expression of YKL-40 was determined by RT-qPCR and Western blot. si-YKL-40-3 was screened out for subsequent experiments. In A549 cells, si-YKL-40-3 and si-NC were transfected and, then, IL-1β (20 ng/mL) was added in for culturing. The expression of YKL-40, IL-6, and IL-8 was determined by RT-qPCR and the expression of multiple factors in the supernatant was measured with the QAH-INF-1 kit. RESULTS: RT-qPCR results showed that IL-1β could up-regulate YKL-40 protein transcription level compared with that of the control group and the difference was statistically significant (P<0.01), but IL-6, TNF-α, and IFN-γ could not up-regulate YKL-40 protein transcription level. Western blot results showed that IL-1β (20 ng/mL) could significantly promote the expression of YKL-40 and, compared with that of the control group, the differences showed by groups treated with different concentrations of IL-1β were all statistical significant (P<0.01). After adding human recombinant YKL-40 protein to A549 cells, the results showed that the expression of inflammatory factors IL-6 and IL-8 was significantly increased and the difference was statistically significant compared with that of the control group (P<0.05). After the expression of YKL-40 was decreased by si-YKL-40-3 transfection, the expression of IL-6 (P<0.05), IL-8 (P<0.05), and other inflammatory factors was inhibited compared with that of the control group. CONCLUSION: YKL-40 can promote the expression and secretion of IL-6, IL-8, and other acute inflammatory factors in A549 cell line, a type Ⅱ alveolar epithelial cell model, thus aggravating the inflammatory response. Targeted inhibition of YKL-40 expression may effectively inhibit inflammatory response. 四川大学学报(医学版)编辑部 2023-09-20 /pmc/articles/PMC10579078/ /pubmed/37866952 http://dx.doi.org/10.12182/20230960201 Text en © 2023《四川大学学报(医学版)》编辑部 版权所有 https://creativecommons.org/licenses/by-nc/4.0/开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议访问 https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0). In other words, the full-text content of the journal is made freely available for third-party users to copy and redistribute in any medium or format, and to remix, transform, and build upon the content of the journal. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may not use the content of the journal for commercial purposes. For more information about the license, visit https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 论 著
YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title_full YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title_fullStr YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title_full_unstemmed YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title_short YKL-40促进Ⅱ型肺泡上皮细胞A549炎症因子的表达
title_sort ykl-40促进ⅱ型肺泡上皮细胞a549炎症因子的表达
topic 论 著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579078/
https://www.ncbi.nlm.nih.gov/pubmed/37866952
http://dx.doi.org/10.12182/20230960201
work_keys_str_mv AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá
AT ykl40cùjìniixíngfèipàoshàngpíxìbāoa549yánzhèngyīnzidebiǎodá